NetworkNewsBreaks – Propanc Health Group Corp. (PPCH) Continues to Advance Pipeline of Anti-Cancer Products
Propanc (OTCQB: PPCH) is a development-stage health care company working to advance its pipeline of new and proprietary treatments for cancer patients suffering from solid tumors toward clinical trials. The company recently issued an update on the progress of additional pending patent applications, noting that it had received a written opinion from the International Search Authority regarding a recent Patent Cooperation Treaty application filed in Australia. The majority of claims in the written opinion were considered novel and inventive, as determined by the authorized officer from the Australian Patent Office. The company’s patent application in Spain, titled "Cancer Treatment," was…